1
|
Quoc TT, Bíró K, Pető Á, Kósa D, Haimhoffer Á, Lekli I, Pallér Á, Bak I, Gyöngyösi A, Fehér P, Bácskay I, Ujhelyi Z. The Role of Amphiphilic Compounds in Nasal Nanoparticles. AAPS PharmSciTech 2024; 25:269. [PMID: 39562402 DOI: 10.1208/s12249-024-03000-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2024] [Accepted: 11/06/2024] [Indexed: 11/21/2024] Open
Abstract
Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results.
Collapse
Affiliation(s)
- Thinh To Quoc
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Krisztina Bíró
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- University Pharmacy, University of Debrecen Clinical Center, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Ágota Pető
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Dóra Kósa
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Ádám Haimhoffer
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - István Lekli
- Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Ádám Pallér
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - István Bak
- Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Alexandra Gyöngyösi
- Department of Pharmacology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Pálma Fehér
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Ildikó Bácskay
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
- Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary
| | - Zoltán Ujhelyi
- Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary.
- Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei körút 98, Debrecen, 4032, Hungary.
| |
Collapse
|
4
|
Lu Y, Qi J, Wu W. Ionic Liquids-Based Drug Delivery: a Perspective. Pharm Res 2022; 39:2329-2334. [PMID: 35974125 DOI: 10.1007/s11095-022-03362-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Accepted: 08/05/2022] [Indexed: 11/30/2022]
Abstract
Ionic liquids (ILs) recently draw attention for addressing unmet needs in biomedicines. By converting solids into liquids, ILs are emerging as novel platforms to overcome some critical drawbacks associated with the application of solid or crystalline active pharmaceutical ingredients (APIs). ILs have shown promise in liquidizing or solubilizing APIs, or as green solvents, novel permeation enhancers or active ingredients, alone or synergistically with APIs. Meanwhile, challenges turn up in company with the deepening understanding of ILs as drug delivery carrier systems. This perspective aims to provide a sketchy overview on the status quo with specific attention paid to new problems arising from the utilization of ILs-based technologies in drug delivery.
Collapse
Affiliation(s)
- Yi Lu
- Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai, 201203, China
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, China
- Fudan Zhangjiang Institute, Shanghai, 201203, China
| | - Jianping Qi
- Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai, 201203, China
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, China
| | - Wei Wu
- Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai, 201203, China.
- Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, 200443, China.
- Fudan Zhangjiang Institute, Shanghai, 201203, China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, 201399, China.
| |
Collapse
|